PF-3758309 hydrochloride NEW
| Price | $74 | $120 | $191 |
| Package | 5mg | 10mg | 25mg |
| Supply Ability: | 10g |
| Update Time: | 2026-07-10 |
Product Details
| Product Name: PF-3758309 hydrochloride | CAS No.: 1279034-84-2 |
| Purity: 98.83% | Supply Ability: 10g |
| Release date: 2026/07/10 |
Product Introduction
Bioactivity
| Name | PF-3758309 hydrochloride |
| Description | PF-3758309 hydrochloride (PF-03758309 hydrochloride) , is a PAK4 inhibitor, is also a n orally bioavailable small-molecule inhibitor of p21-activated kinase 4 (PAK4) with potential antineoplastic activity. PF-3758309 hydrochloride binds to PAK4, inhibiting PAK4 activity and cancer cell growth. PAK4, a serine/threonine kinase belonging to the p21-activated kinase (PAK) family, is often upregulated in a variety of cancer cell types and plays an important role in cancer cell motility, proliferation, and survival. |
| Storage | Powder: -20°C for 3 years | In solvent: -80°C for 1 year Shipping with blue ice/Shipping at ambient temperature. |
| Solubility Information | 10% DMSO+90% Saline : 7.5 mg/mL (14.23 mM), Suspension. DMSO : 45 mg/mL (85.38 mM), Sonication is recommended. |
| Keywords | tumor | survival | signaling | proliferation | PF-3758309 Hydrochloride | PF3758309 hydrochloride | PF-3758309 | PF3758309 | PF-03758309 Hydrochloride | PF03758309 Hydrochloride | PF-03758309 | PF03758309 | PF 3758309 Hydrochloride | PF 3758309 | PF 03758309 Hydrochloride | PF 03758309 | PAK6 | PAK5 | PAK4 | PAK3 | PAK1 | PAK | p21 activated kinases | oncogenic | Inhibitor | inhibit | growth | ATP-competitive | Apoptosis |
| Inhibitors Related | Stavudine | Aceglutamide | Urea | Tamoxifen | Cysteamine hydrochloride | Metronidazole | Citric Acid Triammonium | Formamide | Dimethyl phthalate | Alginic acid | Sodium Molybdate | Sildenafil citrate |
| Related Compound Libraries | Apoptosis Compound Library | Bioactive Compound Library | Kinase Inhibitor Library | Anti-Cancer Clinical Compound Library | Drug Repurposing Compound Library | Inhibitor Library | Orally Active Compound Library | Bioactive Compounds Library Max | Cytoskeletal Signaling Pathway Compound Library | Anti-Cancer Compound Library | Anti-Cancer Drug Library | Anti-Cancer Active Compound Library |
Company Profile Introduction
Target Molecule Corp. (TargetMol) is a global high-tech enterprise, headquartered in Boston, MA, specializing in chemical and biological research product and service to meet the research needs of global customers.
TargetMol has evolved into one of the biggest global compound library and small molecule suppliers and a customer based on 40+ countries. TargetMol offers over 80 types of compound libraries and a wide range of high-quality research chemicals including inhibitors, activator, natural compounds, peptides, inhibitory antibodies, and novel life-science kits, for laboratory and scientific use. Besides, virtual screening service is also available for customers who would like to conduct the computer-aided drug discovery.
You may like
Recommended supplier
| Product name | Price | Suppliers | Update time | |
|---|---|---|---|---|
| $2500.00 |
VIP2Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $65.00 |
VIP4Y
|
TargetMol Chemicals Inc.
|
2026-05-11 | |
| $5.00 |
VIP8Y
|
Jinan Finer Chemical Co., Ltd
|
2026-07-10 |
United States- Since: 2011-01-07
- Address: 36 Washington Street, Wellesley Hill, MA
INQUIRY